Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
09. Oktober 2023 07:50 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
06. Oktober 2023 08:30 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
29. August 2023 07:35 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
10. August 2023 07:35 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
30. Juni 2023 08:25 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
26. Juni 2023 08:25 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023
15. Juni 2023 12:44 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., June 15, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
31. Mai 2023 10:38 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
31. Mai 2023 08:00 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
11. Mai 2023 07:45 ET
|
Reneo Pharmaceuticals, Inc.
Completed enrollment of the pivotal STRIDE study; topline results anticipated 4Q 2023Raised $68.3 million in gross proceeds from a concurrent public offering and private placement IRVINE, Calif.,...